| CAT # | Product Name | Description |
| CPD115335 | Luxdegalutamide; ARV-766 | Luxdegalutamide (ARV-766) is an orally effective protein hydrolysis targeted chimeric (PROTAC) targeting androgen receptor (AR), which can degrade AR resistance related mutants. |
| CPDA601356 | iHSP110-33 | |
| CPDP800487 | TNG462 | TNG-462 is an orally effective selective PRMT5 inhibitor. |
| CPDP801649 | 1,2,4-Triazolo[4,3-c]pyrimidine-5,8-diamine, N5... | EED ligand 1 is a diverse and effective inhibitor that targets the EED subunit of methyltransferase PRC2. |
| CPDM400208 | 6,7-Difluoro-4(3H)-quinazolinone | |
| CPDP801752 | N-(4-quinolinylcarbonyl)Glycine | |
| CPDM400190 | Methyl 5-bromo-2-methyl-3-(trifluoromethyl)benz... | |
| CPDP800126 | IDE397 (GSK-4362676) | |
| CPDP801185 | NST-628 | NST-628 is a MAPK pathway molecular gel with blood-brain barrier permeability, which can inhibit RAF phosphorylation and MEK activation. |
| CPD115153 | NX-2127 | NX-2127 is an orally effective BTK inhibitor. |
| CPDP801764 | VU0448088 (ML253) | VU0448088 (ML253) is an effective positive allosteric modulator of tricyclic muscarinic acetylcholine receptor subtype 4 (M4) that can cross the blood-brain barrier. |
| CPDM400183 | (4′S,5′R)-6”-chloro-4′-... | |
| CPDM400180 | benzyl (2-oxocyclobutyl)carbamate | |
| CPDP801753 | ethyl 2-((3bS,4aR)-5,5-difluoro-3-(trifluoromet... | |
| CPDP801669 | BN104 | BN-104 (BNM-1192) can inhibit the Menin MLL interaction and can be used in cancer research, such as acute myeloid leukemia. |
| CPDM400179 | Cyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid,... | |
| CPDM400178 | Cyclopenta[c]pyrrole-1,2(1H)-dicarboxylic acid,... | |
| CPDP801685 | 2-[(2-fluorobenzoyl)amino]-N-[2-(4-morpholinyl)... | |
| CPD101241 | BAY-2416964；ilantimodum；ilantimod | BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1, example 192. |
| CPDP801684 | 7-methyl-2-((4-methyl-6-(1-methyl-1H-pyrazol-4-... | DNA-PK-IN-12 (compound 31t) is an orally active DNA-PK inhibitor. |
| CPDM400166 | 3-chloro-2-(10-fluoro-8-(prop-1-yn-1-yl)-1,2,3,... | |
| CPD111670 | GDC6036；GDC6036 atropisomers | The GDC6036 anti rotation isomer contains two types of GDC6036 anti rotation isomers. GDC-6036， Also known as RG6330, it is an orally bioavailable, highly efficient, and selective KRAS G12C inhibitor. |
| CPDM400167 | 7-methyl-2-(methylsulfonyl)-9-(tetrahydro-2H-py... | |
| CPDM400131 | 2-((6-amino-5-ethylpyridin-3-yl)amino)-2-oxoace... |
